BANK VONTOBEL/CALL/STRYKER CORP./310/0.1/20.09.24 Share Price

Warrant

DE000VM7NU99

Market Closed - Deutsche Boerse AG 18:50:27 31/05/2024 BST
3.71 EUR +0.27% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./310/0.1/20.09.24
1 month-6.31%
3 months-27.96%
Date Price Change
31/05/24 3.71 +0.27%
30/05/24 3.7 -4.39%
29/05/24 3.87 +11.53%
28/05/24 3.47 +2.06%
27/05/24 3.4 +1.80%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 06:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM7NU9
ISINDE000VM7NU99
Date issued 29/12/2023
Strike 310 $
Maturity 20/09/2024 (110 Days)
Parity 10 : 1
Emission price 2.21
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 5.95
Lowest since issue 1.94
Spread 0.03
Spread %0.80%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus